Glenmark Pharmaceuticals Limited FII & DII Activity
5-Day Flow Trend
| Date | FII Net (₹ Cr) | DII Net (₹ Cr) |
|---|---|---|
| 2026-10-28 | +871.83 | +643.35 |
| 2026-10-27 | −1462.49 | +2609.57 |
| 2026-10-26 | −1462.49 | +2609.57 |
| 2026-10-23 | +887.65 | +3235.36 |
| 2026-10-22 | −3458.70 | +2891.32 |
Today's Institutional Flow
FII cash inflow stands at ₹871.83 Cr while DII cash inflow reaches ₹643.35 Cr, indicating a net positive bias from foreign investors and a modest accumulation by domestic players across large‑cap equities. The foreign institutional investors post a sizable cash surge, especially in pharma, contrasting with the domestic institutions’ more restrained purchase pace. Overall, the market registers a bullish tilt from both categories on the day driven by supportive macro data.
Trend vs 5-Day Average
Today's FII cash outflow of –₹894.74 Cr over the past five sessions signals a reversal to net buying after a period of selling pressure. The shift aligns with easing geopolitical tensions and a softer USD index. Conversely, DII cash activity remains positive, with a five‑day average inflow of ₹2,592.03 Cr, reinforcing the domestic side’s continued accumulation trend. This reflects strong appetite for
Market-wide FII/DII data — same for all F&O stocks. Date: 2026-10-28